Lipase — supply status, manufacturers & alternatives

Lipase

—

🇦🇺 AUST R 274498 · Alexion Pharmaceuticals Australasia Pty Ltd

In supply · Australia

Cotazym Ecs 20

In supply · 🇦🇺 Australia · short in🇨🇦 CA

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Controlled substance
Active ingredient (INN)	Lipase
Brand names	Cotazym Ecs 20
Therapeutic category	Auto-created by Health Canada — Drug Shortages Database scraper

Marketing-authorisation holders	Alexion Pharmaceuticals Australasia Pty Ltd, TROPHIC CANADA LTD.

Registrations on file	2

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders2 registrations · 2 MA holders

Product	Strength	Form	Market	MA holder	Status
KANUMA sebelipase alfa rce	2 mg	—	🇦🇺 AU	Alexion Pharmaceuticals Australasia Pty Ltd	Active
Vitamins A-C-E Plus Lipase Tab	—	tablet	🇨🇦 CA	TROPHIC CANADA LTD.	Cancelled

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.